NOUVEAU MEDICAMENT POUR L'INHIBITION DE L'AGREGATION DES PROTEINES IMPLIQUEES DANS DES MALADIES ASSOCIEES A L'AGREGATION DES PROTEINES ET/OU DES MALADIES NEURODEGENERATIVES
The present invention relates to a compound represented by formula (E). Thepresent invention also relates to acompound represented by the formula (E) for use in the treatment or preventionof diseases linked to protein aggregation and/orneurodegenerative diseases. Moreover, the present invention relates topharmaceutical and diagnostic compositions comprisingthe compound of the invention as well as to a kit. Furthermore, the presentinvention relates to a method of imaging deposits ofaggregated protein. A kit for preparing a detectably labelled compound of thepresent invention is also disclosed. Formula (E)wherein X, Y and L are independently nondirectionally selected from -C(R1)(R2)-, -C(R3)=, -N(R4)-, -N=, -N(R5)=, -O- and -S-;M and Z are independently nondirectionally selected from formula (I) andformula (II).